Latest news for Panamera Hldgs (OTC:PHCI) Stock

Panamera Holdings Corp, formerly Panamera Healthcare Corp is a development stage company helping clients navigate the complexities of a healthcare system in transition.

PANAMERA HOLDINGS CORP by Panamera Holdings Corporation

Panamera Holdings Corp

Shares of CrowdStrike Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) closed at $364.3 apiece on Tuesday and fell by more than 5% in premarket trading on Wednesday.
Technical analysis pointed towards a bullish trend after the Texas-based cybersecurity technology company reported its third-quarter earnings.
What Happened: Despite the fallout from a faulty software update in July, the company reported its highest-ever revenue in the <a href="https://www.benzinga.com/news/earnings/24/11/42202105/crowdstrike-beats-q3-earnings-revenue-estimates-cybersecurity-company-highlights-incredible-success-retaining-customers-following-it-outage">third quarter</a>, surpassing the $1 billion mark, beating the consensus estimate of $982.36 million, <a href="https://www.benzinga.com/earnings">curated by Benzinga</a>.
Technical Analysis: From a technical perspective, the analysis of daily moving averages shows support for the CrowdStrike stock.
Despite falling over 5% in premarket trading on Wednesday, at $344 a piece, CrowdStrike&#8217;s stock is above its 20, 50, and 200-day simple moving averages, suggesting a largely bullish trend.
On the other hand, investors can also benefit from some potential selling opportunities &#8211; the relative strength index of 68.19 suggests CrowdStrike stock is near the &#8220;overbought&#8221; territory.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033758/Stock-Tech-Chart-1024x576.png" alt="" class="wp-image-666877" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033758/Stock-Tech-Chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033758/Stock-Tech-Chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033758/Stock-Tech-Chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033758/Stock-Tech-Chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033758/Stock-Tech-Chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
See Also: <a href="https://www.benzinga.com/general/market-summary/24/11/42206673/trumps-running-mate-vice-president-pick-and-venture-capitalist-jd-vance-holds-etfs-bitcoin-and-more-here-is-a-look-at-his-portfolio">JD Vance&#8217;s Investment Playbook Has Bitcoin And ETFs: Here&#8217;s What Else The VP-Elect Is Betting O</a>n
Why It Matters: Even though the third-quarter non-GAAP earnings beat estimates, according to the GAAP measures in the company&#8217;s press release, it reported a net loss of $16.8 million, as compared to an income of $26.7 million in the third quarter of the previous fiscal.
Additionally, the third-quarter GAAP loss from operations was reported at $55.7 million, compared to income of $3.2 million in the third quarter of fiscal 2024.
The July disruption resulted in flight cancellations globally and impacted sectors such as banking, healthcare, and hospitality. Delta Air Lines Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) <a href="https://www.benzinga.com/news/24/10/41562639/delta-air-lines-sues-crowdstrike-for-500m-over-july-outage-that-disrupted-flights-affecting-1-3m-cus">sued the company last month</a>, estimating that the outage cost it $500 million.
To this, the chief financial officer Burt W. Podbere, said, &#8220;We expect Q4 free cash flow to reflect a significantly more pronounced July 19 impact in comparison to Q3.&#8221;
Analyst Views: According to <a href="https://www.benzinga.com/quote/CRWD/analyst-ratings">Benzinga Pro data</a>, CrowdStrike has a consensus price target of $338.11 apiece based on the ratings of 42 analysts.
The high is $440 per share issued by Keybanc on July 2 and the low is $265 apiece issued by Scotiabank on Aug. 14.
The average price target of $393.33 between Evercore ISI Group, Rosenblatt, and Keybanc, implies a 14.67% upside for CrowdStrike.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="380" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033815/CRWD-analysts-1024x380.png" alt="" class="wp-image-666878" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033815/CRWD-analysts-1024x380.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033815/CRWD-analysts-300x111.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033815/CRWD-analysts-768x285.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27033815/CRWD-analysts.png 1060w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/42186167/michael-saylors-microstrategy-convertible-notes-to-buy-bitcoin-offer-no-interest-so-why-are-investors-rushing-to-buy-them">Michael Saylor&#8217;s MicroStrategy Convertible Notes To Buy Bitcoin Offer No Interest, So Why Are Investors Rushing To Buy Them?</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Equities

News

Technicals

Markets

Analyst Ratings

Trading Ideas

General

CRWD

CrowdStrike Stock's Technical Analysis Shows Bullish Trend As It Navigates July Fallout To Deliver Record Q3 Revenue: Here's More

Needham analyst Gil Blum maintains Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Buy and lowers the price target from $205 to $202.

Price Target

SRPT

Needham Maintains Buy on Sarepta Therapeutics, Lowers Price Target to $202

The total gross proceeds to the Company from the Offering and the concurrent private placements are expected to be approximately US$413.4 million, assuming the underwriters of the Offering do not exercise their option to purchase additional ADSs, or approximately US$452.4 million if the underwriters choose to fully exercise their option to purchase additional ADSs.

IPOs

PONY

Pony AI Prices $413.4M Initial Public Offering Of 20M American depositary shares At $13/ADS

Ascendiant Capital analyst Lucas Ward maintains Aclarion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) with a Buy and lowers the price target from $1.5 to $1.3.

ACON

Ascendiant Capital Maintains Buy on Aclarion, Lowers Price Target to $1.3

During a recent episode of the &#8220;All-In Podcast,&#8221; Chamath Palihapitiya discussed the potential impact of Elon Musk and Vivek Ramaswamy using the Department of Government Efficiency (DOGE) to simplify the U.S. tax code.
What Happened: Palihapitiya highlighted the significant public response to a post by the official X page of DOGE, which questioned opinions about the IRS. He noted that many people expressed a desire for a flat tax system, suggesting a willingness to pay a flexible tax rate if it meant simplifying the tax code.
&#8220;If these guys basically use DOGE as a mechanism to shrink the tax code, create a flat tax, potentially&#8230;the idea of just cutting this all the way down and then finding through that process what you actually need, I think can find America 100-200 basis points of GDP growth. It could be an economic renaissance.&#8221;
Palihapitiya emphasized that such changes would require Congressional approval but could lead to a more rational fiscal approach.
Furthermore, Palihapitiya believes this initiative could empower average Americans by giving them a sense of control over government spending, marking a moral and symbolic victory in fiscal policy.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="DOGE unveils a roadmap, Unlocking GDP Growth, WW3 escalation, Fat cell memory" width="500" height="281" src="https://www.youtube.com/embed/pnmDeIgW3EQ?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/commodities/24/11/42164230/amid-trumps-drill-baby-drill-pledge-strategist-predicts-us-oil-supply-will-see-marginal-increase-does-the-world-need-that-much-oil?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Amid Trump&#8217;s &#8216;Drill Baby, Drill&#8217; Pledge, Strategist Predicts US Oil Supply Will See &#8216;Marginal&#8217; Increase:</a>
Why It Matters: The discussion by Palihapitiya comes in the wake of President-elect Donald Trump&#8216;s <a href="https://www.benzinga.com/news/global/24/11/41927289/trump-appoints-elon-musk-and-vivek-ramaswamy-to-lead-doge-targeting-bureaucracy-and-65-trillion-federal-spending-we-will-not-go-gently">announcement to appoint </a>Musk and Ramaswamy to lead the new department. It aims to overhaul federal agencies and cut down on government spending.
The initiative, likened to &#8220;The Manhattan Project,&#8221; is set to dismantle bureaucracy, reduce regulations, and eliminate wasteful expenditures. The department&#8217;s work is expected to be completed by July 4, 2026, aligning with America&#8217;s 250th independence anniversary. Trump&#8217;s statement emphasized the role of Musk and Ramaswamy in paving the way for his administration to dismantle government bureaucracy.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42152684/musk-tweet-sparks-dogecoin-surge-fuels-speculation-on-x-payments?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Musk Tweet Sparks Dogecoin Surge, Fuels Speculation On X Payments</a></li>
</ul>
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
Image via Shutterstock

Government

Regulations

Chamath Palihapitiya Says Elon Musk, Vivek Ramaswamy-Led DOGE Could Usher In 'Economic Renaissance' With A 100-200 Basis Point GDP Surge

Needham analyst Quinn Bolton maintains Ambarella (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) with a Buy and raises the price target from $90 to $100.

AMBA

Needham Maintains Buy on Ambarella, Raises Price Target to $100

Needham analyst Scott Berg reiterates Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) with a Buy and maintains $300 price target.

Reiteration

WDAY

Needham Reiterates Buy on Workday, Maintains $300 Price Target

<ul>
<li>Approval is based on&nbsp;Phase III NATALEE data showing Kisqali (ribociclib) plus adjuvant endocrine therapy (ET) demonstrated clinically meaningful invasive disease-free survival (iDFS) benefit in patients with stage II or III HR+/HER2- early breast cancer (EBC), consistent across all subgroups.</li>
<li>With this broad indication, nearly twice as many EBC patients in Europe, including those with node-negative disease, could now be eligible for treatment with Kisqali to help reduce their risk of recurrence.</li>
<li>Despite ET, more than one-third of people diagnosed with stage II and III EBC will experience a return of their cancer in the long term, often as incurable advanced disease.</li>
<li>Recently presented four-year analysis of the ongoing NATALEE trial showed a deepening iDFS benefit after completion of three-year treatment period.</li>
</ul>

Biotech

Large Cap

Health Care

The European Commission Has Approved Novartis' Kisqali (Ribociclib) In Combination With An Aromatase Inhibitor For The Adjuvant Treatment Of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer At High Risk Of Recurrence

Macro Economic Events

Econ #s

Economics

Germany GfK Consumer Climate For December -23.3 Vs. -18.8 Est.; -18.4 (Revised) Prior

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) with a Buy and maintains $102 price target.

VKTX

HC Wainwright & Co. Reiterates Buy on Viking Therapeutics, Maintains $102 Price Target

Analysts are closely examining the impact of&nbsp;Michael Saylor, co-founder of&nbsp;MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), on exchange-traded funds (ETFs) that are<a href="https://www.benzinga.com/markets/equities/24/11/42186167/michael-saylors-microstrategy-convertible-notes-to-buy-bitcoin-offer-no-interest-so-why-are-investors-rushing-to-buy-them"> linked to the company&#8217;s performance</a>. This comes amid a significant surge in MicroStrategy&#8217;s stock, driven by its substantial Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) holdings.
What Happened: The volatility of&nbsp;MicroStrategy has led to significant returns for ETFs tied to its performance. The stock has surged 416.19% year-to-date, impacting various ETFs.
The&nbsp;Bitwise Crypto Industry Innovators ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITQ#NYSE">BITQ</a>) with 18.35% MSTR holding saw a rise of 68.58% so far this year, while the&nbsp;Schwab Crypto Thematic ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STCE#NYSE">STCE</a>), which gives 14.4% exposure to MSTR, increased by 55.07%.
The&nbsp;T-Rex 2x Long MSTR Daily&nbsp;Target&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/MSTU#BATS">MSTU</a>) experienced a remarkable 453.76% gain, and the&nbsp;Defiance Daily Target 2x Long&nbsp;MSTR ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTX#NASDAQ">MSTX</a>) rose by 309.09%, Barron&#8217;s <a href="https://pro.benzinga.com/">reported</a> on Wednesday. 
Both T-Rex and Defiance have hedged with inverse ETFs, but the&nbsp;T-Rex 2x Inverse MSTR Daily&nbsp;Target (MSTZ) holds&nbsp;only $155 million in assets.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42152684/musk-tweet-sparks-dogecoin-surge-fuels-speculation-on-x-payments?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Musk Tweet Sparks Dogecoin Surge, Fuels Speculation On X Payments</a>
Matthew Tuttle, manager of the T-Rex ETF, attributes this phenomenon to &#8220;The Michael Saylor effect,&#8221; likening it to the influence of other high-profile CEOs like Elon Musk and Jensen Huang, reported Barron&#8217;s. Tuttle acknowledges the risk, noting that from a fundamental perspective, MicroStrategy&#8217;s valuation appears inflated.
Why It Matters: On Monday, MicroStrategy <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42159139/microstrategy-shares-rise-in-monday-pre-market-as-michael-saylor-reveals-mstr-generating-500m-daily-amid-bitcoins-surge">shares climbed 5.93% in pre-market </a>trading before <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42208320/michael-saylors-microstrategy-plunges-23-in-5-sessions-while-bitcoin-slips-under-6-gary-black-quips-dont-say-i-didnt-warn-you">closing the session</a> in the red. Over the weekend, Saylor revealed that the company is generating $500 million daily as Bitcoin edges closer to the $100,000 milestone.
According to <a href="http://pro.benzinga.com">Benzinga Pro data,</a> MicroStrategy has a consensus price target of $449.5 based on the ratings of 12 analysts. The high is $690 issued by BTIG on Dec. 11, 2023. The low is $140 issued by Jefferies on Nov. 10, 2022. The average price target of $563.33 between TD Cowen, Barclays, and Benchmark implies a 41.90% upside for MicroStrategy.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/11/42151809/michael-saylor-reveals-microstrategy-is-making-500m-a-day-with-bitcoin-may-very-well-be-the-most-profitable-company-in-the-us-growing-the-fastest-right-now?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Michael Saylor Reveals MicroStrategy Is &#8216;Making $500M A Day&#8217; With Bitcoin: &#8216;May Very Well Be The Most Profitable Company In The US Growing The Fastest Right Now&#8217;</a></li>
</ul>
Photo by JOCA_PH on Shutterstock

ETFs

$BTC

BITQ

MSTR

ETF Opportunities Trust T-Rex 2X Long MSTR Daily Target ETF

MSTU

MSTX

STCE

MicroStrategy-Linked ETFs Skyrocket 400% This Year: Is This 'The Michael Saylor Effect'?

Shares of Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) rose sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/quote/NTNX/news">better-than-expected first-quarter financial results.</a>
Nutanix reported quarterly earnings of 42 cents per share which beat the analyst consensus estimate of 31 cents per share. The company reported quarterly sales of $590.96 million which beat the analyst consensus estimate of $571.78 million.
Nutanix shares jumped 8.8% to $78.71 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>HWH International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) gained 82.1% to $1.12 in pre-market trading.</li>
<li>Cyclerion Therapeutics, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) rose 72.8% to $2.35 in pre-market trading.</li>
<li>Infobird Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) gained 56% to $2.87 in pre-market trading after declining around 6% on Tuesday.</li>
<li>T Stamp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDAI#NASDAQ">IDAI</a>) gained 39.7% to $0.51 in pre-market trading after jumping around 103% on Tuesday.</li>
<li>Quantum Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) climbed 24.8% to $21.50 in pre-market trading after dipping more than 20% on Tuesday.</li>
<li>Ambarella, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) gained 24.3% to $85.00 in pre-market trading after the company reported better-than-expected third-quarter financial results.</li>
<li>Creative Media &amp; Community Trust Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCT#NASDAQ">CMCT</a>) gained 15% to $0.2767 in pre-market trading.</li>
<li>Creative Global Technology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTL#NASDAQ">CGTL</a>) gained 13.6% to $4.44 in pre-market trading. Creative Global Technology priced its IPO at $4 per share.   </li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) gained 10.9% to $2.44 in pre-market trading after dipping 20% on Tuesday. The company announced a registered direct offering of 50 million shares at $2 per unit.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Primega Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) shares tumbled 89.2% to $11.65 in pre-market trading after surging 919% on Tuesday.</li>
<li>CIMG Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMG#NASDAQ">IMG</a>) shares fell 24.4% to $1.21 in pre-market trading after jumping 154% on Tuesday.</li>
<li>Grifols, S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRFS#NASDAQ">GRFS</a>) shares fell 17.7% to $7.18 in pre-market trading.</li>
<li>Blue Star Foods Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSFC#NASDAQ">BSFC</a>) fell 15.6% to $0.3120 in pre-market trading. Blue Star Foods shares jumped 55% on Tuesday after the company announced a $1.5 million buyback program.</li>
<li>3D Systems Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) fell 15% to $2.90 in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Citius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) declined 14.2% to $3.56 in pre-market trading after surging 24% on Tuesday.</li>
<li>Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) fell 13.1% to $123.24 in today's pre-market trading. Dell reported better-than-expected earnings for its third quarter, while sales missed estimates.</li>
<li>Guess?, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) fell 12.7% to $15.13 in pre-market trading after the company reported a year-over-year decrease in third-quarter adjusted EPS results.</li>
<li>Workday, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) shares dipped 10.1% to $242.95 in pre-market trading after the company revised its FY25 subscription revenue guidance.</li>
<li>HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) dipped 8.7% to $35.69 in pre-market trading. HP reported in-line earnings for its fourth quarter, while sales topped estimates. HP said it expects first-quarter adjusted earnings of between 70 cents and 76 cents per share, versus the 85 cent estimate, and fiscal 2025 earnings of between $3.45 and $3.75 per share, versus the $3.60 estimate.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42188912/jim-cramer-linde-is-a-terrific-company-sees-another-stock-up-75-as-not-done">Jim Cramer: Linde Is A &#8216;Terrific&#8217; Company, Sees Another Stock Up 75% As &#8216;Not Done&#8217;</a></li>
</ul>

BSFC

CGTL

CMCT

CTXR

CYCN

DELL

GRFS

IDAI

IFBD

NTNX

PGHL

QMCO

RGTI

Why Nutanix Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

BingEx Reported Q3 Revenue Of $164.6M, Adj EPS Of $0.18

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) with a Buy and maintains $12 price target.

FEMY

HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $12 Price Target

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Esperion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPR#NASDAQ">ESPR</a>) with a Buy and maintains $16 price target.

ESPR

HC Wainwright & Co. Reiterates Buy on Esperion Therapeutics, Maintains $16 Price Target

MARA Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>)&nbsp;exhorted the incoming Donald Trump administration to expand domestic Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) mining operations, emphasizing the significance of the U.S.&nbsp;controlling a larger portion of&nbsp;the global hash rate for economic sovereignty.
What Happened:&nbsp;In an X post on Tuesday, the company highlighted the increasing competitiveness of Bitcoin mining and the potential economic implications of not securing a significant&nbsp;share of the global hash rate. 
The company stressed that by&nbsp;controlling a larger portion of&nbsp;the&nbsp;hash rate—the computational power used to validate transactions and add new blocks to the blockchain—the U.S. can protect its transactions from foreign interference.
&#8220;By controlling hash rate, a nation can prioritize access to block space, preventing adversarial nations from censoring or manipulating its transactions,&#8221; MARA added.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">With <a href="https://twitter.com/SenLummis?ref_src=twsrc%5Etfw">@SenLummis</a>&#39;s <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> Act in the pipeline, the US must lead in mining, blockspace, &amp; hashrate so we can ensure that "&#8230;a sovereign can have sovereignty." &#8211; <a href="https://twitter.com/fgthiel?ref_src=twsrc%5Etfw">@fgthiel</a> Read more: <a href="https://t.co/UNbfDAsZpr">https://t.co/UNbfDAsZpr</a>
&mdash; MARA (@MARAHoldings) <a href="https://twitter.com/MARAHoldings/status/1861426696710193605?ref_src=twsrc%5Etfw">November 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42208108/surge-in-bitcoin-dogecoin-and-other-cryptos-boosting-home-ownership-among-low-income-americans-says-treasury-department">Surge In Bitcoin, Dogecoin And Other Cryptos Boosting Home Ownership Among Low-Income Americans, Says Treasury Department</a>
For the uninitiated, Bitcoin&#8217;s blockspace represents the finite capacity available in each block to include transaction data. 
Access to block space is vital for participating in the Bitcoin economy, and miners or mining pools with a higher hash rate can prioritize transactions in a block.
Why It Matters: Mara&#8217;s recommendation follows President Trump&#8217;s assured support to the industry, with a vision to <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39363038/donald-trump-speaks-on-bitcoin-mining-wants-all-the-remaining-bitcoin-to-be-made-in-the-us">mine all remaining Bitcoins in the U.S</a>.
The pledge, aligning with his &#8220;America First&#8221; policy, seemed to be directed against China, which, despite a ban on cryptocurrency trading and mining,&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40985461/china-controls-55-of-bitcoin-hashrate-despite-crypto-ban-but-the-us-is-catching-up" target="_blank" rel="noreferrer noopener">still controls over 50% of the global Bitcoin hash rate</a>.
According to Bitbo <a href="https://charts.bitbo.io/miner-monthly-revenue/" target="_blank" rel="noreferrer noopener">data</a>, miner revenue in November increased by 3.4% from the previous month, primarily driven by the jump in Bitcoin&#8217;s price following Trump&#8217;s election victory.
The broader corporate Bitcoin mining sector has seen gains since the event, with CoinShares Valkyrie Bitcoin Miners ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGMI#NASDAQ">WGMI</a>) rising 18%.
Price Action:&nbsp;At the time of writing, Bitcoin was exchanging hands at $93,388.09, up 0.57% in the last 24 hours, according to&nbsp;<a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.&nbsp;Shares of MARA were up 3.04% in pre-market trading hours.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42207257/historic-win-for-crypto-court-overturns-treasury-sanctions-on-tornado-cash-associated-token-skyrockets-430">&#8216;Historic Win For Crypto:&#8217; Court Overturns Treasury Sanctions On Tornado Cash, Associated Token Skyrockets 430%</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>
Image Via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

MARA

WGMI

MARA Urges Incoming Trump Administration To Boost US Bitcoin Mining Operations To Prevent Manipulation From 'Adversarial' Nations

Small Cap Consumer Research analyst Eric Beder reiterates Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) with a Buy and maintains $3 price target.

VNCE

Small Cap Consumer Research Reiterates Buy on Vince Holding, Maintains $3 Price Target

Small Cap Consumer Research analyst Eric Beder reiterates Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) with a Buy and maintains $41 price target.

Small Cap Consumer Research Reiterates Buy on Build-A-Bear Workshop, Maintains $41 Price Target

Needham analyst Quinn Bolton reiterates Analog Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) with a Hold.

Needham Reiterates Hold on Analog Devices

Piper Sandler analyst Brent Bracelin downgrades Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) from Overweight to Neutral and lowers the price target from $285 to $270.

Comments

Panamera Hldgs

News

Latest news for Panamera Hldgs (OTC:PHCI) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga